During the past decade, Assiut Clinic conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Assiut Clinic" are "Breast Cancer" (1 trials), "Colo-rectal Cancer" (1 trials), "Colon Cancer" (1 trials), "Foot Infection Tinea Pedis" (1 trials) and "Skin Cancer" (1 trials). Many other conditions were trialed in "Assiut Clinic" in a lesser frequency.

Most popular intervention types in "Assiut Clinic" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Cetuximab nanoparticles" (1 trials), "Cream Base" (1 trials), "Oral approved anticancer drug" (1 trials), "Pomegrante and Ginkgo biloba group" (1 trials) and "Quantum dots coated with veldoreotide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Assiut Clinic" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Assiut Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Assiut Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Assiut Clinic, 4 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".